The evolution of data in healthcare in combination with policy advancements demonstrates how far the field has come but also brings up new challenges.
At the kickoff to the 2-day combined AcademyHealth National Health Policy Conference and Health Datapalooza meeting Monday, Melinda Buntin, PhD, professor and Mike Curb Chair of the Department of Health Policy at Vanderbilt University, challenged the audience of so-called data nerds and policy wonks to come up with new solutions that are bipartisan, or even, she said, referring to her old life as a government health economist, nonpartisan.
Data and policy are integral to each other, both she and Niall Brennan, president and chief executive officer of the Health Care Cost Institute, said as they recapped the progress and challenges in both areas over the past decade or 2.
Compared with 2010, 2020 looks robust, Brennan said in their joint data and policy plenary.
Ten years ago, consumers could not download their own machine-readable claims data and send them to apps, while researchers had no easy public access to Medicaid or Medicaid Advantage data sets.
In 2020, electronic health records are a reality, as is Blue Button 2.0, the HHS and CMS effort to make health information interoperable with an open application program interface for a tech-savvy generation.
However, Brennan pointed out, there is “still no comprehensive way of measuring successes or failures in the healthcare system.”
Different payers hold onto claims data in their own silos, he said, which prevents the public from knowing more about the variation in costs for different procedures or even how many procedures a specialist has performed before a patient makes an appointment.
And legislation to enact a nationwide all-claims database didn’t get through the Senate last year, Brennan said, leaving employers and employees in the dark about what really drives healthcare costs.
Moreover, since EHRs are largely a creation of Washington, DC, culture, he joked that they include many of the same features: “southern efficiency and northern charm.”
More unforgiving, in his view, is that the nation’s largest EHR vendor last month urged hospitals to cosign a letter to HHS Secretary Alex Azar—who is scheduled to speak at the meeting Tuesday morning—to ask for a delay in the release of final interoperability and patient information access rules from the Office of the National Coordinator (ONC) for Health Information Technology (HIT), the HHS office responsible for implementing and advancing the use of HIT.
The rules are expected to be released shortly and seek to end information blocking and give patients more control and choice over their data; the vendor, Epic, reportedly claims to be concerned about patient privacy.
However, with many new players in the HIT market, Brennan said, “we need a frank conversation about privacy” and more discussion about privacy as a “civil right.”
Before asking the audience to think about new solutions, Buntin recapped health policy achievements before getting into continued challenges.
“We have a political consensus that we need to expand access to care,” she said, including the need to move to value-based care and a recognition that patients with preexisting conditions need protection from being denied health insurance, which was enshrined in the Affordable Care Act (ACA). That, and the provision that young adults can stay on their parents insurance until age 26, are 2 of the most popular features of the ACA.
The ACA also gave rise to the Center for Medicare and Medicaid Innovation (CMMI), which gave CMS the ability to approve pilots without Congressional approval, and allowed states to expand Medicaid coverage.
In addition, she said, “We’ve also come an enormous way to appreciating the role that social determinants of health and social risk factors play. This represents a sea change from thinking that patients were to blame for noncompliance or readmissions to understanding that pursuing the objective of health required seeing patients as part of collective social systems.”
Even though recent results from the Camden Coalition show the difficulty of this task, Buntin said she does not think that such efforts are doomed.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen